Literature DB >> 8623771

Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas.

T Terada1, Y Nakanuma.   

Abstract

Aberrant or incomplete glycosylation of mucins results in expression of T, Tn, and sialyl-Tn (STn) antigens in various malignant neoplasms. MUC-1 gene product (a mucin core protein of mammary type) is known to alter or overexpress in several malignant tumors. However, expression of these mucin-related antigens has rarely been examined in intraductal papillary-mucinous neoplasm (IPN) of the pancreas. The authors examined immunohistochemically the expression of these antigens and MUC-1 gene product in nine IPN. In normal pancreas (n = 5), pancreatic ducts did not express T, Tn, or STn antigens, but expressed MUC-1 gene product. Among the nine IPNs, two (22%) expressed T antigen, nine (100%) expressed Tn antigen, and seven (78%) expressed STn antigen. MUC-1 gene product was expressed in nine (100%) IPNs. In invasive ductal adenocarcinoma of the pancreas (n = 6), all cases showed strong expression of Tn and STn antigens and the MUC-1 gene product, but expressed no T antigen. The expression of these antigens and MUC-1 gene product was focal in IPN, whereas it was diffuse in invasive ductal adenocarcinoma of the pancreas. These data suggest that aberrant or incomplete glycosylation occurs in epithelial mucins of IPN, that IPN is a borderline or low grade malignant neoplasm in terms of mucin-related antigen expression, and that mucin core protein (MUC-1 gene product) does not alter during pancreatic ductal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623771     DOI: 10.1093/ajcp/105.5.613

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

Review 1.  The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.

Authors:  Huiyuan Tang; Peter Hsueh; Doron Kletter; Marshall Bern; Brian Haab
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Noninvasive Intracystic Oncocytic Papillary Neoplasm of the Gall Bladder.

Authors:  Tadashi Terada
Journal:  J Gastrointest Cancer       Date:  2016-09

3.  An immunohistochemical study of a primary signet-ring cell carcinoma of the ampulla of vater: a case report.

Authors:  Tadashi Terada
Journal:  J Gastrointest Cancer       Date:  2013-12

4.  Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Authors:  P J Limburg; D A Ahlquist; J A Gilbert; J J Harrington; G G Klee; P C Roche
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Non-invasive intraductal papillary neoplasms of the common bile duct: a clinicopathologic study of six cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

6.  Malignant intraductal oncocytic papillary neoplasm of the common bile duct.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-01-09

7.  Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.

Authors:  Seema Chugh; Srikanth Barkeer; Satyanarayana Rachagani; Rama Krishna Nimmakayala; Naveenkumar Perumal; Ramesh Pothuraju; Pranita Atri; Sidharth Mahapatra; Ishwor Thapa; Geoffrey A Talmon; Lynette M Smith; Xinheng Yu; Sriram Neelamegham; Jianxin Fu; Lijun Xia; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Gastroenterology       Date:  2018-08-04       Impact factor: 22.682

8.  Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.

Authors:  Rita Pinto; Ana S Carvalho; Tim Conze; Ana Magalhães; Gianfranco Picco; Joy M Burchell; Joyce Taylor-Papadimitriou; Celso A Reis; Raquel Almeida; Ulla Mandel; Henrik Clausen; Ola Söderberg; Leonor David
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

9.  COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.

Authors:  Bianca T Hofmann; Laura Schlüter; Philip Lange; Baris Mercanoglu; Florian Ewald; Aljonna Fölster; Aeint-Steffen Picksak; Sönke Harder; Alexander T El Gammal; Katharina Grupp; Cenap Güngör; Astrid Drenckhan; Hartmut Schlüter; Christoph Wagener; Jakob R Izbicki; Manfred Jücker; Maximilian Bockhorn; Gerrit Wolters-Eisfeld
Journal:  Mol Cancer       Date:  2015-05-29       Impact factor: 27.401

Review 10.  Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.

Authors:  N Moniaux; M Andrianifahanana; R E Brand; S K Batra
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.